Tomasz Hajdukiewicz

Elblag, WN, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Fabry disease: The crucial role of the interhospital Heart Team in the diagnostic process of this rare disease.

Fabry disease: The crucial role of the interhospital Heart Team in the diagnostic process of this rare disease.

Journal: Kardiologia polska

Published: October 20, 2025

Fabry disease: The crucial role of the interhospital Heart Team in the diagnostic process of this rare disease.

Fabry disease: The crucial role of the interhospital Heart Team in the diagnostic process of this rare disease.

Journal: Kardiologia polska

Published: October 20, 2025

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?

Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin?

Journal: Cardiology journal

Published: February 13, 2025

Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.

Prolonged antithrombotic treatment after de-escalation of dual antiplatelet therapy in patients after acute coronary syndrome - which strategy should be applied? The ELECTRA-SIRIO 2 investigators standpoint.

Journal: International journal of cardiology

Published: April 06, 2024

Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.

Early treatment with inhibitors of P2Y12 receptor in patients with ST-segment elevation myocardial infarction - 2023 ESC recommendations and scientific evidence. Is clinical evidence sufficient to suggest a move towards precision medicine? The ELECTRA-SIRIO 2 investigators' viewpoint.

Journal: Cardiology journal

Published: March 26, 2024

Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.

Maintenance therapy with a P2Y12 receptor inhibitor after cangrelor in patients with acute coronary syndrome. The ELECTRA-SIRIO 2 investigators' viewpoint.

Journal: Cardiology journal

Published: November 27, 2023

Reversal of Platelet Inhibition in Patients Receiving Ticagrelor.

Reversal of Platelet Inhibition in Patients Receiving Ticagrelor.

Journal: Reviews in cardiovascular medicine

Published: June 28, 2022

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.

A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study.

Journal: Cardiology journal

Published: March 24, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026